Demographic and baseline laboratory data of the study patients.
| Parameter | Results |
|---|---|
| N | 22a) |
| Median age in years (range) | 17 (3–72) |
| Median BAT score (range) | 4.5 (3–11) |
| PT in seconds: mean (±2SD) | 13 (±2.83) |
| aPTT in seconds: mean (±2SD) | 30.9 (±6.85) |
| Fibrinogen level in g/dL: mean (±2SD) | 3.17 (±1.43) |
| Hemoglobin in g/L: median (range) | 113 (57–148) |
| Total leucocyte count ×109/L: median (range) | 7.2 (2.7–113.5) |
| Platelet count ×109/L: median (range) | 217 (123–425) |
| VWF antigen assay: % median (range) | 123.05 (68.8–223.6) |
| VWF GPIbR (RiCoF activity) assay: % median (range) | 109.3 (58.7–221.3) |
a)Includes 22 non-thrombocytopenic (parallel LTA and FCA data available). Two thrombocytopenic patients (only FCA data available) were discussed separately.
Abbreviations: aPTT, activated partial thromboplastin time; BAT, bleeding assessment tool; PT, prothrombin time; RiCoF, ristocetin cofactor activity assay; VWF, von Willebrand factor.
Blood Res 2021;56:109~118 https://doi.org/10.5045/br.2021.2020232
© Blood Research
© 2024. BLOOD RESEARCH All rights reserved. Powered by INFOrang Co., Ltd